Summary of SALIX PHARMACEUTICALS LTD

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

SLXP > SEC Filings for SLXP > Form 8-K on 12-Feb-2013

All Recent SEC Filings

Show all filings for SALIX PHARMACEUTICALS LTD | Request a Trial to NEW EDGAR Online Pro

Form 8-K for SALIX PHARMACEUTICALS LTD

12-Feb-2013

Other Events

Item 8.01. Other Events.

On February 1, 2013, Salix Pharmaceuticals, Inc., a wholly owned subsidiary of Salix Pharmaceuticals, Ltd. (the "Company") , received a subpoena from the U.S. Attorney's Office for the Southern District of New York requesting documents regarding the Company's sales and promotional practices for Xifaxan® (rifaximin), Relistor® (methylnaltrexone bromide) and Apriso® (mesalamine). The Company is in the process of responding to the subpoena and intends to cooperate fully with the subpoena and related government investigation. The Company cannot predict or determine the impact of this inquiry on our financial condition or results of operations.

Add SLXP to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for SLXP - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.